Showing results (111-120 of 2,753) with videos related to
Sort By:
Pageof 276
Pharmacogenomics|September 7, 2020
Effects of rare CYP2C9 alleles on stable warfarin doses in Chinese Han patients with atrial fibrillationDongxu Wang, Da-Peng Dai, Hualan Wu, et al.Pharmacogenomics|January 21, 2020
Effects of CYP2C19*2 polymorphisms on the efficacy and safety of phenazepam in patients with anxiety disorder and comorbid alcohol use disorderMichael S Zastrozhin, Valentin Y Skryabin, Marco Torrado, et al.Pharmacogenomics|January 24, 2019
Association between genetic polymorphisms and angiotensin-converting enzyme inhibitor-induced cough: a systematic review and meta-analysisGuangyan Mu, Qian Xiang, Shuang Zhou, et al.Pharmacogenomics|November 28, 2018
Involvement of miRNA polymorphism in mucositis development in childhood acute lymphoblastic leukemia treatmentÁngela Gutierrez-Camino, Maitane Umerez, Elixabet Lopez-Lopez, et al.Pharmacogenomics|March 9, 2018
SNPs affecting the clinical outcomes of regularly used immunosuppressantsHuan-Yu Meng, Zhao-Hui Luo, Bo Hu, et al.Pharmacogenomics|March 9, 2018
Allelic frequencies of 60 pharmacogene variants assessed within a Burmese population residing in northeast Indiana, USACarrie C Hoefer, Emily J Brick, Ann Savariar, et al.Pharmacogenomics|November 19, 2013
Issues surrounding the health economic evaluation of genomic technologiesJames Buchanan, Sarah Wordsworth, Anna SchuhPharmacogenomics|November 19, 2013
Genome-wide association study in NSAID-induced acute urticaria/angioedema in Spanish and Han Chinese populationsJosé Antonio Cornejo-García, Lieh-Bang Liou, Natalia Blanca-López, et al.Pharmacogenomics|November 19, 2013
Pediatric perspective on pharmacogenomicsAdam Stevens, Chiara De Leonibus, Daniel Hanson, et al.Pharmacogenomics|December 20, 2013
SLC19A1 80G allele as a biomarker of methotrexate-related gastrointestinal toxicity in Portuguese rheumatoid arthritis patientsAurea Lima, Miguel Bernardes, Hugo Sousa, et al.Pageof 276